Steven P. Gelone - 31 Oct 2022 Form 4 Insider Report for Nabriva Therapeutics plc (NBRVF)

Role
President and COO, Director
Signature
/s/ J. Christopher Naftzger, by power of attorney
Issuer symbol
NBRVF
Transactions as of
31 Oct 2022
Net transactions value
-$7.62
Form type
4
Filing time
01 Nov 2022, 17:06:47 UTC
Previous filing
11 Oct 2022
Next filing
08 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NBRVF Ordinary Shares Tax liability $7.62 -3 -0.02% $2.54* 14,442 31 Oct 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These ordinary shares were withheld by the Issuer in order to satisfy tax withholding obligations upon the vesting of certain restricted share units.